Analysis of sulindac and metabolites by combined isotope dilution-radioimmunoassay.
Sulindac, a new anti-inflammatory agent, and its sulfone and sulfide metabolites were conjugated to bovine serum albumin by the N-hydroxysuccinimide active ester procedure. Antiserum from rabbits immunized with each of these haptens exhibited extensive cross-reactivity, precluding differential analyses of the three species by displacement assay without prior separation. Therefore, an analytical method based on a combination of isotope dilution and radioimmunoassay was devised. A known mixture of the three chemical species, each labeled with tritium, was equilibrated with plasma or urine samples, reisolated chromatographically, and quantitated by binding to an appropriate immunoglobulin. The radiolabeled materials thus served as recovery standards as well as labeled antigens for each displacement assay. Sulindac and each of its metabolites in plasma or urine at concentrations as low as 500 ng/sample were differentially determined by this procedure. However, since an extraction is required, several milliliters of plasma can be used for each sample, thus increasing the actual sensitivity of the assay.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000032:analysis* / Q000276:immunology; D001597:Benzylidene Compounds / Q000032:analysis* / Q000276:immunology; D003429:Cross Reactions; D007192:Indenes / Q000032:analysis* / Q000276:immunology; D008722:Methods; D011817:Rabbits / Q000276:immunology; D011863:Radioimmunoassay; D011865:Radioisotope Dilution Technique; D014316:Tritium
D000893:Anti-Inflammatory Agents; D001597:Benzylidene Compounds; D007192:Indenes; D014316:Tritium